Clinical Trial Update: Metformin in Non-Alcoholic Fatty Liver Disease [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/3 trial of metformin for non-alcoholic fatty liver disease, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University Hospital, Aker | Conditions: Fatty Liver | Phase 2, Phase 3 | Status: UNKNOWN